APEXXNAR

This brand name is authorized in Austria, Croatia, Estonia, Finland, Poland, Romania.

Active ingredients

The drug APEXXNAR contains one active pharmaceutical ingredient (API):

1
UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
 
Read more about Pneumococcus, purified polysaccharides antigen

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 APEXXNAR Suspension for injection MPI, EU: SmPC European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
J07AL02 Pneumococcus, purified polysaccharides antigen conjugated J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AL Pneumococcal vaccines
Discover more medicines within J07AL02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1875135, 1875146, 1875157
FI Lääkealan turvallisuus- ja kehittämiskeskus 182303, 458025
PL Rejestru Produktów Leczniczych 100467708
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W68478001, W68478002, W68478003, W68478004, W68478005, W68478006

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈